The organizations will collaborate on the application of artificial intelligence to medical imaging, and the automation of diagnostic and interventional ultrasound.
GE HealthCare partners with Mayo Clinic to accelerate work on imaging and AI Read More »
The results indicate patients might select in-person office visit over telehealth options if they feel they need a higher level of care or closer proximity to other tests and assessments, according to a study from Epic Research.
Telehealth visits billed at a lower level of service than office visits, study finds Read More »
Jeffrey Brewer hopes to see more integrated solutions for people with diabetes, starting with the company’s partnership with Abbott.
Bigfoot CEO talks Abbott acquisition, future of diabetes tech Read More »
Chinese purchases represent 10% to 20% of revenues on average for leading companies in the life science tools sector, according to Jefferies research.
Hospital, lab equipment makers brace for China demand slowdown Read More »
Janssen will be recast as Johnson & Johnson Innovative Medicine, while the company’s medical device business will remain Johnson & Johnson MedTech.
J&J to phase out Janssen name in corporate rebrand Read More »
The timeline of the two upcoming models could be pushed back if Congress doesn’t come to a funding agreement and the government shuts down, CMMI head Liz Fowler said.
CMMI teases new behavioral, maternal health models launching this year Read More »
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label extension of KAFTRIO®.
YS Biopharma Co., Ltd. (NASDAQ: YS) (“YS Biopharma” or the “Company”) today announced that the United States Patent and Trademark Office has issued it a patent covering the Company’s PIKA YS-HBV-002, an immunotherapeutic vaccine designed to treat patients suffering from chronic hepatitis B virus (“HBV”) infection.
Merck (NYSE: MRK) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant treatment of adults with non-small cell lung cancer (NSCLC), who are at high risk of recurrence following complete resection and platinum-based chemotherapy.
Neoss Group, a leading innovator in dental implant solutions, is proud to announce the fast and easy-to-use wireless intraoral scanner, NeoScan™ 2000.
Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000 Read More »
